Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Change in Cash (2016 - 2025)

Pediatrix Medical (MD) has disclosed Change in Cash for 17 consecutive years, with $35.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Cash fell 72.1% to $35.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $145.3 million, a 7.26% decrease, with the full-year FY2025 number at $145.3 million, down 7.26% from a year prior.
  • Change in Cash was $35.2 million for Q4 2025 at Pediatrix Medical, down from $115.3 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $126.1 million in Q4 2024 to a low of -$854.2 million in Q1 2021.
  • A 5-year average of -$37.4 million and a median of $13.4 million in 2023 define the central range for Change in Cash.
  • Peak YoY movement for Change in Cash: soared 4405.1% in 2023, then crashed 1663.78% in 2024.
  • Pediatrix Medical's Change in Cash stood at $29.5 million in 2021, then tumbled by 96.08% to $1.2 million in 2022, then skyrocketed by 4405.1% to $52.1 million in 2023, then soared by 142.15% to $126.1 million in 2024, then plummeted by 72.1% to $35.2 million in 2025.
  • Per Business Quant, the three most recent readings for MD's Change in Cash are $35.2 million (Q4 2025), $115.3 million (Q3 2025), and $125.8 million (Q2 2025).